ABBVIE
- Country
- π«π·France
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- $346B
- Website
- http://www.abbvie.com
Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 101
- Registration Number
- NCT02632175
- Locations
- πΊπΈ
MNGI Digestive Health, P. A. /ID# 147294, Minneapolis, Minnesota, United States
π΅π±Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego /ID# 147310, Wroclaw, Dolnoslaskie, Poland
π΅π±Instytut Centrum Zdrowia Matki Polki /ID# 169017, Lodz, Lodzkie, Poland
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
- Conditions
- Interventions
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 1629
- Registration Number
- NCT02629159
- Locations
- πΊπΈ
Precision Research Org, LLC /ID# 143092, Miami Lakes, Florida, United States
πΊπΈDM Clinical Research /ID# 151357, Tomball, Texas, United States
πΏπ¦Arthritis Clinical Research Tr /ID# 144874, Cape Town, Western Cape, South Africa
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
- Conditions
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 3043
- Registration Number
- NCT02629172
- Locations
- π―π΅
Mori Clinic /ID# 157489, Osaka, Japan
π―π΅Aichi Medical University Hosp /ID# 152220, Nagakute, Aichi, Japan
π―π΅Nagoya City University Hospital /ID# 153642, Nagoya-shi, Aichi, Japan
Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab
- Conditions
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2019-03-22
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 91
- Registration Number
- NCT02627924
The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, Β± Dasabuvir, Β± Ribavirin in France
- Conditions
- First Posted Date
- 2015-12-02
- Last Posted Date
- 2019-06-17
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 735
- Registration Number
- NCT02618928
- Locations
- π«π·
Hopital Pitie Salpetriere /ID# 145566, Paris, France
π«π·CHR Orleans - Hopital de la Source /ID# 147250, Orleans CEDEX 2, Centre-Val De Loire, France
π«π·Hopital Universitaire Purpan /ID# 150141, Toulouse, Haute-Garonne, France
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, Β± Dasabuvir, Β± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)
- Conditions
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 472
- Registration Number
- NCT02615145
Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan
- Conditions
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 100
- Registration Number
- NCT02616380
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
- Conditions
- First Posted Date
- 2015-11-23
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 213
- Registration Number
- NCT02611713
- Locations
- πΊπΈ
University of Pennsylvania /ID# 161135, Philadelphia, Pennsylvania, United States
π·π΄Spitatlul Clinic Colentina /ID# 144447, Bucharest, Romania
πΊπΈMercy St. Mary's Health Center /ID# 144418, Grand Rapids, Michigan, United States
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
- Conditions
- Interventions
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2019-12-10
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 105
- Registration Number
- NCT02609659
[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 4
- Registration Number
- NCT02606630
- Locations
- π¬π§
Site Reference ID/Investigator# 141461, Whitechapel, United Kingdom
π¬π§Site Reference ID/Investigator# 141463, London, United Kingdom